54 related articles for article (PubMed ID: 10577940)
1. Malignant Abnormalities in Male BRCA Mutation Carriers: Results From a Prospectively Screened Cohort.
Mano R; Tamir S; Kedar I; Benjaminov O; Baniel J; Tabachnik T; Margel D
JAMA Oncol; 2018 Jun; 4(6):872-874. PubMed ID: 29710070
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry.
Frevert ML; Dannehl D; Jansen L; Hermann S; Schäffler H; Huwer S; Janni W; Juhasz-Böss I; Hartkopf AD; Taran FA
Arch Gynecol Obstet; 2024 Jun; 309(6):2811-2819. PubMed ID: 38472501
[TBL] [Abstract][Full Text] [Related]
3. Differences in Ovarian and Other Cancers Risks by Population and
Sekine M; Nishino K; Enomoto T
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356066
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.
Feng Y; Spezia M; Huang S; Yuan C; Zeng Z; Zhang L; Ji X; Liu W; Huang B; Luo W; Liu B; Lei Y; Du S; Vuppalapati A; Luu HH; Haydon RC; He TC; Ren G
Genes Dis; 2018 Jun; 5(2):77-106. PubMed ID: 30258937
[TBL] [Abstract][Full Text] [Related]
5. The Epidemiology of Male Breast Cancer.
Ferzoco RM; Ruddy KJ
Curr Oncol Rep; 2016 Jan; 18(1):1. PubMed ID: 26694922
[TBL] [Abstract][Full Text] [Related]
6. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Im KM; Kirchhoff T; Wang X; Green T; Chow CY; Vijai J; Korn J; Gaudet MM; Fredericksen Z; Shane Pankratz V; Guiducci C; Crenshaw A; McGuffog L; Kartsonaki C; Morrison J; Healey S; Sinilnikova OM; Mai PL; Greene MH; Piedmonte M; Rubinstein WS; ; Hogervorst FB; Rookus MA; Collée JM; Hoogerbrugge N; van Asperen CJ; Meijers-Heijboer HE; Van Roozendaal CE; Caldes T; Perez-Segura P; Jakubowska A; Lubinski J; Huzarski T; Blecharz P; Nevanlinna H; Aittomäki K; Lazaro C; Blanco I; Barkardottir RB; Montagna M; D'Andrea E; ; Devilee P; Olopade OI; Neuhausen SL; Peissel B; Bonanni B; Peterlongo P; Singer CF; Rennert G; Lejbkowicz F; Andrulis IL; Glendon G; Ozcelik H; ; Toland AE; Caligo MA; ; Beattie MS; Chan S; ; Domchek SM; Nathanson KL; Rebbeck TR; Phelan C; Narod S; John EM; Hopper JL; Buys SS; Daly MB; Southey MC; Terry MB; Tung N; Hansen TV; Osorio A; Benitez J; Durán M; Weitzel JN; Garber J; Hamann U; ; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Eeles R; Izatt L; Paterson J; Brewer C; Hodgson S; Morrison PJ; Porteous M; Walker L; Rogers MT; Side LE; Godwin AK; Schmutzler RK; Wappenschmidt B; Laitman Y; Meindl A; Deissler H; Varon-Mateeva R; Preisler-Adams S; Kast K; Venat-Bouvet L; Stoppa-Lyonnet D; Chenevix-Trench G; Easton DF; Klein RJ; Daly MJ; Friedman E; Dean M; Clark AG; Altshuler DM; Antoniou AC; Couch FJ; Offit K; Gold B
Hum Genet; 2011 Nov; 130(5):685-99. PubMed ID: 21597964
[TBL] [Abstract][Full Text] [Related]
7. Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.
Ding YC; Steele L; Kuan CJ; Greilac S; Neuhausen SL
Breast Cancer Res Treat; 2011 Apr; 126(3):771-8. PubMed ID: 20927582
[TBL] [Abstract][Full Text] [Related]
8. How old is this mutation? - a study of three Ashkenazi Jewish founder mutations.
Greenwood CM; Sun S; Veenstra J; Hamel N; Niell B; Gruber S; Foulkes WD
BMC Genet; 2010 May; 11():39. PubMed ID: 20470408
[TBL] [Abstract][Full Text] [Related]
9. Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.
Allain DC
J Mol Diagn; 2008 Sep; 10(5):383-95. PubMed ID: 18687797
[TBL] [Abstract][Full Text] [Related]
10. Second cancers in patients with male breast cancer: a literature review.
Grenader T; Goldberg A; Shavit L
J Cancer Surviv; 2008 Jun; 2(2):73-8. PubMed ID: 18648975
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.
Tai YC; Domchek S; Parmigiani G; Chen S
J Natl Cancer Inst; 2007 Dec; 99(23):1811-4. PubMed ID: 18042939
[TBL] [Abstract][Full Text] [Related]
12. BRCA2 mutations in 154 finnish male breast cancer patients.
Syrjäkoski K; Kuukasjärvi T; Waltering K; Haraldsson K; Auvinen A; Borg A; Kainu T; Kallioniemi OP; Koivisto PA
Neoplasia; 2004; 6(5):541-5. PubMed ID: 15548363
[TBL] [Abstract][Full Text] [Related]
13. Hereditary breast cancer in Jews.
Rubinstein WS
Fam Cancer; 2004; 3(3-4):249-57. PubMed ID: 15516849
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer.
Basham VM; Lipscombe JM; Ward JM; Gayther SA; Ponder BA; Easton DF; Pharoah PD
Breast Cancer Res; 2002; 4(1):R2. PubMed ID: 11879560
[TBL] [Abstract][Full Text] [Related]
15. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
Figer A; Irmin L; Geva R; Flex D; Sulkes J; Sulkes A; Friedman E
Br J Cancer; 2001 Feb; 84(4):478-81. PubMed ID: 11207041
[TBL] [Abstract][Full Text] [Related]
16. Founder BRCA1/2 mutations among male patients with breast cancer in Israel.
Struewing JP; Coriaty ZM; Ron E; Livoff A; Konichezky M; Cohen P; Resnick MB; Lifzchiz-Mercerl B; Lew S; Iscovich J
Am J Hum Genet; 1999 Dec; 65(6):1800-2. PubMed ID: 10577940
[No Abstract] [Full Text] [Related]
17. The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
Hubert A; Peretz T; Manor O; Kaduri L; Wienberg N; Lerer I; Sagi M; Abeliovich D
Am J Hum Genet; 1999 Sep; 65(3):921-4. PubMed ID: 10441598
[No Abstract] [Full Text] [Related]
18. Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.
Chodick G; Struewing JP; Ron E; Rutter JL; Iscovich J
Eur J Med Genet; 2008; 51(2):141-7. PubMed ID: 18158280
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
